Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
Titel:
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
Auteur:
Santos, C. Azuara, D. Viéitez, J.M. Páez, D. Falcó, E. Élez, E. López-López, C. Valladares, M. Robles-Díaz, L. García-Alfonso, P. Bugés, C. Durán, G. Salud, A. Navarro, V. Capellá, G. Aranda, E. Salazar, R.